RSS

Issue 18.1

This case study details Schubert-Pharma’s automated solution for a small-component packaging task. more

Opinion

Various aspects must be considered when deciding upon the best coating technology. Here, the authors describe their recent study comparing three different coating technologies’ efficiency in a pellet coating process. more

, , , , , Opinion

What to watch out for over the coming 12 months that should have an impact on the pharma landscape, according to some industry leaders… more

Opinion

Drug research and development is often likened to finding a needle in a haystack with multiple targets and many potential variables with which they can interact. So, what technological advancements are impacting development timelines… more

Opinion

We sit down with Dirk Leister, technical marketing manager, Thermo Fisher Scientific, to find out more about hot melt extrusion and the company’s new automated, integrated system designed for continuous production of drug implants. more

Opinion

In this article, NSF International goes into detail about what the potential ramifications of Brexit may be on the regulatory landscape in pharma. more

Opinion

Here, Dan Anslow, UK sales manager, Crest Solutions, shares some key tips and insights, learned through partnering with pharmaceutical manufacturers that have already successfully implemented solutions for serialisation, aggregation and Track & Trace more

Opinion

Here, Vikash Patel, senior regulatory specialist for ELC Group, gives us an update on the regulatory developments impacting the pharma industry as a result of Brexit. more

Opinion

In this article, Hervé Sibillat, general manager, ADM-SIO, discusses the important considerations in managing the natural variability of plant-based pharmaceutical ingredients. more

Opinion

In this article, Michael Adeogun, head of Life Sciences and Health at NPL examines how and where measurement can help government and industry grasp the opportunities the Strategy and Sector Deal offer. more

Opinion

All signs are that the life sciences and healthcare market is ripe for disruption, with ecommerce coming into its own in the sector. Scott Allison, president Life Sciences & Healthcare, DHL, lists five reasons as to why it is happening now. more

Opinion

Avoiding operational downtime is a major issue for all organisations, as the related disruption and financial consequences can prove catastrophic. Here, Tim Wynn-Jones suggests that organisations need to start taking it seriously. more

Opinion

In the first of the Tech Talk series, Novarum founder and BBI group head of mobile, Dr Neil Polwart, goes through his seven key tips that should be kept at front of mind when trying to implement a successful mHealth strategy. more

Opinion

About a year ago, Schott set out to elevate pharmaceutical glass quality to a new level with its perfeXion initiative. EPM sat down with Dr Patrick Markschläger, Schott Tubing, to discuss the impact of glass tubing on future packaging challenges. more

Opinion

As we embark on a difficult flu season, I look at why infection rates vary so much year on year and the potential universal vaccine one company is progressing through the clinical development stages. more

Opinion